1. Home
  2. LINK vs LPCN Comparison

LINK vs LPCN Comparison

Compare LINK & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Interlink Electronics Inc.

LINK

Interlink Electronics Inc.

HOLD

Current Price

$3.26

Market Cap

59.5M

Sector

Technology

ML Signal

HOLD

Logo Lipocine Inc.

LPCN

Lipocine Inc.

HOLD

Current Price

$7.40

Market Cap

61.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LINK
LPCN
Founded
1984
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.5M
61.8M
IPO Year
2007
2011

Fundamental Metrics

Financial Performance
Metric
LINK
LPCN
Price
$3.26
$7.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$8.67
$15.00
AVG Volume (30 Days)
17.1K
129.0K
Earning Date
05-12-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
46.18
EPS
N/A
N/A
Revenue
$11,679,000.00
$1,976,677.00
Revenue This Year
$8.30
N/A
Revenue Next Year
$34.68
$74.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.76
$2.52
52 Week High
$15.15
$12.37

Technical Indicators

Market Signals
Indicator
LINK
LPCN
Relative Strength Index (RSI) 45.90 42.23
Support Level $2.84 $2.87
Resistance Level $3.43 $8.35
Average True Range (ATR) 0.18 0.68
MACD 0.01 -0.13
Stochastic Oscillator 30.50 20.68

Price Performance

Historical Comparison
LINK
LPCN

About LINK Interlink Electronics Inc.

Interlink Electronics Inc is a sensor and printed electronics company operating in two principal sensor technology divisions: force/touch sensors, and gas and environmental sensors. It designs, develops, manufactures and sells a range of force-sensing and gas-sensing technologies that incorporate its proprietary materials technology, firmware and software into a portfolio of standard sensor-based products and custom sensor system solutions. Its force-sensing products and solutions include sensor components, subassemblies, modules products that support effective, efficient cursor control and novel three-dimensional user inputs. Its Human Machine Interface technology platforms are deployed in a wide range of markets including consumer electronics, automotive, industrial, and medical.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: